With a lack of published studies helping to quantify key tasks for oncology pharmacists, the Hematology/Oncology Pharmacy Association (HOPA), in partnership with the Hematology/Oncology Practice and Research Network (PRN) of the American College of Clinical Pharmacy (ACCP), surveyed hem/onc pharmacists with the goal of creating a consensus on the time necessary to complete common patient and non-patient care-related responsibilities.

The resulting research article represents the first comprehensive consensus statements on the average time for a U.S.-based oncology pharmacist to complete common care-related tasks. These endorsed statements may be utilized in measuring and evaluating hem/onc pharmacist workload and productivity.

The process and resulting consensus statements have been published in the Journal of Oncology Pharmacy Practice.


Authors: Shawn P. Griffin, PharmD, BCOP; Jessie Signorelli, PharmD, BCOP; Farah Raheem, PharmD, BCOP; Kristin Adler, M.Ed; Lydia L. Benitez, PharmD, BCOP; Rose M. Cheng, PharmD, BCOP; Emily Dotson, PharmD, BCOP; Marielle Fares, PharmD; Beejal R. Ganti, PharmD, BCOP; Erin Hickey Zacholski, PharmD, BCOP; Aubrey R. Lasko, PharmD, BCOP; Amanda B. Lewallen, PharmD, BCOP; Alia C. Lynch, PharmD, BCOP; Nikola Paulic, PharmD, BCOP; David Quach, PharmD, BCPS, BCOP; Vishnuprabha Vogel, PharmD, BCOP; Matt Yacobucci, PharmD, BCOP; and Grazyna Riebandt, PharmD, BCOP

Read the full article here

HOPA logo
Advocacy

HOPA Signs Letters Defending Medicaid, NIH, and More Against Funding Cuts

HOPA has joined forces with multiple national health organizations to speak out against proposed cuts to Medicaid, the NIH, and the future of optimized cancer care.

HOPA logo
Advocacy

Together We Can Save Cancer Research - and Lives

In the past two decades, extraordinary progress has been made in the fight against cancer. However, with Congress determined to reduce federal spending, entire cancer research, prevention, and surveillance programs are on the verge of elimination.

Advocacy

HOPA Signs Letter in Support of Cancer Research Funding and Infrastructure

Thirty-three organizations have signed a letter in support of cancer research funding amid Executive Orders that threaten the stability of research infrastructure.